Form 4/A for SRTA Strata Critical Medical, Inc.

Accepted 2024-04-17 00:00:00 ET · period of report 2024-04-03 · accession 0001779128-24-000057 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
A	2024-04-17	2024-04-03	SRTA	Tomkiel Melissa M.	Pres, GC	S - Sale	$3.28	-11.7K	1.30M	-0.9%	-$38.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A common stock, $0.0001 par value per share	2024-04-03	S	D	11,734	$3.28	1,302,223	D	—	—	(F2) Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. (F1) The original Form 4, filed on April 5, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on April 3, 2024 as a total of 22,836 shares sold when in fact only 11,734 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 11,102 shares. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.175 to $3.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.